Viewing Study NCT01711034


Ignite Creation Date: 2025-12-25 @ 2:20 AM
Ignite Modification Date: 2025-12-27 @ 11:51 PM
Study NCT ID: NCT01711034
Status: COMPLETED
Last Update Posted: 2016-04-05
First Post: 2012-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced Cancer
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module